ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Kidney transplantation"

  • 2021 American Transplant Congress

    Infectious Complications After Belatacept Conversion in Kidney Transplant

    J. E. Marvin1, D. Amenyedor1, M. M. Azar2, K. Belfield1, V. Do1, R. Formica3, E. Cohen1

    1Pharmacy, Yale New Haven Hospital, New Haven, CT, 2Section of Infectious Diseases, Yale School of Medicine, New Haven, CT, 3Section of Nephrology, Yale School of Medicine, New Haven, CT

    *Purpose: Tacrolimus (tac), a calcineurin inhibitor, is associated with multiple adverse effects when used for immunosuppression following kidney transplant (KT). Belatacept (bela) is a monoclonal…
  • 2021 American Transplant Congress

    Tacrolimus Therapeutic Exposure is Not Consistently Predicted by Target Troughs or CYP3A5 Variants in Stable Renal Transplant Recipients

    K. Tornatore1, K. Attwood2, D. Brazeau3, B. Murray4

    1Pharmacy Practice, School of Pharmacy; University at Buffalo, Buffalo, NY, 2Biostatistics, School of Public Health; University at Buffalo, Buffalo, NY, 3Pharmacy Practice, School of Pharmacy; Marshall University, Huntington, WV, 4Medicine, Erie County Medical Center Corp., Buffalo, NY

    *Purpose: Tacrolimus (TAC) immunosuppression requires therapeutic trough monitoring post-transplant due to notable interpatient pharmacokinetic(PK) variability which may be attributed to CYP3A5 polymorphisms. We investigated the…
  • 2021 American Transplant Congress

    The Effect of the Different Donor-Derived HLA T-Cell Epitope Targets on the Development of T Cell-Mediated Rejection After Kidney Transplantation

    A. Senev, E. Van Loon, M. Emonds, M. Naesens

    Microbiology, Immunology and Transplantation, KU Leuven, Leuven, Belgium

    *Purpose: Many kidney allografts fail due to rejections caused by the donor and recipient HLA incompatibility. Recent studies have shown that HLA-DR and DQ mismatches…
  • 2021 American Transplant Congress

    Disparities in Access to Listing in Rural Populations Post-KAS Implementation

    S. H. Nguyen1, R. R. Redfield2, N. Neidlinger1, D. P. Foley1, D. B. Kaufman1, J. T. Adler3

    1Department of Surgery, University of Wisconsin School of Medicine and Public Health, Madison, WI, 2Department of Surgery, University of Pennsylvania, Philadelphia, PA, 3Department of Surgery, Brigham and Women’s Hospital, Boston, MA

    *Purpose: One major goal of the Kidney Allocation System (KAS) was to improve access to transplantation. The impact of KAS on rural populations has been…
  • 2021 American Transplant Congress

    The Trifecta Study: Calibrating Circulating Donor-Derived Cell-Free DNA at the Time of Indication Biopsies Against the Molecular Phenotype of the Biopsy Reveals a Prominent Association with NK Cell Genes

    P. Halloran1, Z. Demko2, A. Prewett2, J. Reeve1, P. Billings2

    1Alberta Transplant Applied Genomics Centre, Edmonton, AB, Canada, 2Natera Inc., San Carlos, CA

    *Purpose: The international, multicenter, prospective Trifecta study was designed to calibrate dd-cfDNA% measurements in blood at the time of indication biopsy against the molecular characteristics…
  • 2021 American Transplant Congress

    Use of Donor Blood Expedites HCV Genotyping and Allows Earlier DAA Initiation for Recipients of HCV+ Kidneys

    B. Lonze, N. Ali, R. Montgomery, Z. Stewart Lewis

    Tranplant Institute, NYU Langone Health, New York, NY

    *Purpose: Utilization of HCV viremic donor kidneys for transplant into HCV naïve recipients has become more widespread, yet best practices governing the initiation, timing or…
  • 2021 American Transplant Congress

    Pre-transplant Lower Urinary Tract Dysfunction in Men is a Risk Factor for Adverse Outcomes Following Renal Transplantation

    M. J. Goldstein1, B. R. Schleich2, T. Carrea1, Y. Yushkov1, N. Cheng3, R. Harrison3, R. Munver3, D. Fromer3

    1Organ Transplant, Hackensack University Medical Center, Hackensack, NJ, 2Patient Safety and Quality, Hackensack University Medical Center, Hackensack, NJ, 3Urology, Hackensack University Medical Center, Hackensack, NJ

    *Purpose: The expanding age criteria for candidacy for renal transplantation, in conjunction with prolonged waiting time for deceased donor kidneys has created new challenges for…
  • 2021 American Transplant Congress

    Pathways and Factors That Confer Therapeutic Properties of Adipose Derived Regenerative Cells in Reducing Ischaemia Reperfusion Injury in Kidney Transplantation

    R. Lathan, P. Mark, M. Clancy, R. Touyz

    Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, United Kingdom

    *Purpose: Studies in our rat model of ischemic reperfusion injury (IRI) demonstrate improved kidney function post injection of non-cultured autologous adipose-derived regenerative cells (ADRC). The…
  • 2021 American Transplant Congress

    Remote Monitoring Using Mobile Phlebotomy and Donor-derived Cell-free DNA in Kidney Transplant Recipients During the Covid-19 Pandemic

    N. Ali1, J. Miles2, V. Tatapudi1, R. Montgomery1

    1NYU Langone, New York, NY, 2Medical Science Liason, CareDx, Brisbane, CA

    *Purpose: The rapid shift to telemedicine and remote monitoring of kidney transplant recipients (KTRs) during COVID-19 aimed to mitigate exposure risk for this vulnerable population.…
  • 2021 American Transplant Congress

    GENiE in a Bottle – Renasight Testing in the Kidney Transplant Setting – A Single Center Experience

    Y. A. Qazi1, W. Mon1, N. Ioannou2, M. Smogorzewski1

    1Keck Medical Center at USC, Los Angeles, CA, 2Natera, San Carlos, CA

    *Purpose: Renasight™(Natera), a recently available genetic test provides analysis on 382 genes associated with adult-onset kidney disease, covering clinical categories (cystic, tubular, glomerular, complement-related, congenital…
  • « Previous Page
  • 1
  • …
  • 80
  • 81
  • 82
  • 83
  • 84
  • …
  • 531
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences